Market News How it works Learn FAQ
| RCT 0.1222 60.58% | NU 12.375 -18.37% | EWZ 33.44 -21.48% | TGL 0.2449 10.56% | BBD 2.87 -29.48% | SRTM 0.3384 -21.36% | ITUB 7.555 -21.87% | AZTR 1.72 140.56% | XP 15.775 -48.13% | NVD 4.02 -4.06% | SHFS 0.0979 -26.06% | SPCX 148.81 0.89% | CLRO 4.75 46.15% | SOXL 90.94 8.83% | GCDT 0.1442 -18.11% | PBR 22 -15.90% | NWGL 0.0822 0.24% | VALE 11.895 -4.07% | TSLL 10.9402 12.09% | INTC 90.94 4.58% | SGRY 23.095 46.63% | CRWV 56.79 4.71% | NVDA 215.6 2.20% | BITO 10.6301 -1.85% | GPUS 0.1862 10.24% | SOXS 47.855 -8.78% | RBNE 0.17 -10.53% | NOK 8.6738 6.56% | ABEV 2.78 -15.76% | RWM 14.455 -0.65% | IREN 26.12 4.88% | JBLU 2.2648 -13.72% | INTR 4.525 -37.07% | TSLG 5.4701 12.32% | SBS 4.615 -27.89% | TQQQ 68.649 3.56% | XTND 2.1 18.64% | SPRC 1.5 37.61% | SPDN 8.4901 -0.58% | TSLA 395.035 6.13% | AAL 12.1593 0.41% | LUCD 0.5437 32.29% | SID 0.9326 -20.97% | SQQQ 38.275 -3.54% | PBR-A 19.3171 -17.90% | CIFR 7.9 -0.50% | GGB 4.725 -7.35% | T 21.035 0.50% | QID 14.195 -2.44% | NFLX 63.265 -3.93%
BLBelite Bio, Inc logo

Belite Bio, Inc (BLTE)

NASDAQ Capital Market · Currency in USD
$144.21 ▼ -3.12 (-2.12%)
As of Oct 26, 1:31 PM ET. Market open.

Summary

Previous Close
$147.33
Open
$149.12
Day's Range
$143.66 – $149.12
52 Week Range
$90.77 – $200.00
Volume
79,159
Avg. Volume
187,784
Market Cap
$5.81B
Beta (5Y Monthly)
-1.23
PE Ratio (TTM)
--
EPS (TTM)
-$2.55
Earnings Date
Nov 9, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$245.83

Profile: Belite Bio, Inc

Sector
Healthcare
Industry
Biotechnology
Full-time employees
41
CEO
Yu-Hsin Lin

Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies. The firm's primary therapeutic areas include atrophic age-related macular degeneration and autosomal recessive Stargardt disease. Its flagship drug candidate, LBS-008, is an investigational oral medication administered once daily.

Earnings

Next report: Mon, Nov 9, 2026
EPS estimate -$0.79
DateEst.Actual
Aug 12, 2026-$0.73-$0.70Beat
May 20, 2026-$0.60-$0.34Beat
Mar 2, 2026-$0.56-$0.38Beat
Nov 10, 2025-$0.53-$0.65Miss
Aug 11, 2025-$0.47-$0.50Miss
May 13, 2025-$0.36-$0.45Miss

Analyst view

Consensus price target
$245.83 ▲ +70.5%
Range $206.00 – $303.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on BLTE and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.